141 related articles for article (PubMed ID: 8354025)
1. The pharmacokinetics of morphine and morphine glucuronides in kidney failure.
Osborne R; Joel S; Grebenik K; Trew D; Slevin M
Clin Pharmacol Ther; 1993 Aug; 54(2):158-67. PubMed ID: 8354025
[TBL] [Abstract][Full Text] [Related]
2. Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites.
Sear JW; Hand CW; Moore RA; McQuay HJ
Br J Anaesth; 1989 Jan; 62(1):28-32. PubMed ID: 2644963
[TBL] [Abstract][Full Text] [Related]
3. Morphine-6-glucuronide disposition in renal impairment.
Hanna MH; D'Costa F; Peat SJ; Fung C; Venkat N; Zilkha TR; Davies S
Br J Anaesth; 1993 May; 70(5):511-4. PubMed ID: 8318321
[TBL] [Abstract][Full Text] [Related]
4. Morphine intoxication in renal failure: the role of morphine-6-glucuronide.
Osborne RJ; Joel SP; Slevin ML
Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1548-9. PubMed ID: 3087512
[TBL] [Abstract][Full Text] [Related]
5. Morphine-6-glucuronide might mediate the prolonged opioid effect of morphine in acute renal failure.
Bodd E; Jacobsen D; Lund E; Ripel A; Mørland J; Wiik-Larsen E
Hum Exp Toxicol; 1990 Sep; 9(5):317-21. PubMed ID: 2261246
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of codeine in end-stage renal disease.
Guay DR; Awni WM; Findlay JW; Halstenson CE; Abraham PA; Opsahl JA; Jones EC; Matzke GR
Clin Pharmacol Ther; 1988 Jan; 43(1):63-71. PubMed ID: 3335120
[TBL] [Abstract][Full Text] [Related]
7. The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function.
Portenoy RK; Thaler HT; Inturrisi CE; Friedlander-Klar H; Foley KM
Clin Pharmacol Ther; 1992 Apr; 51(4):422-31. PubMed ID: 1563212
[TBL] [Abstract][Full Text] [Related]
8. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide.
Osborne R; Joel S; Trew D; Slevin M
Clin Pharmacol Ther; 1990 Jan; 47(1):12-9. PubMed ID: 2295214
[TBL] [Abstract][Full Text] [Related]
9. Renal tubular transport of morphine, morphine-6-glucuronide, and morphine-3-glucuronide in the isolated perfused rat kidney.
Van Crugten JT; Sallustio BC; Nation RL; Somogyi AA
Drug Metab Dispos; 1991; 19(6):1087-92. PubMed ID: 1687015
[TBL] [Abstract][Full Text] [Related]
10. Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides in rabbits receiving single and repeated doses of morphine.
Mignat C; Jansen R; Ziegler A
J Pharm Pharmacol; 1995 Feb; 47(2):171-5. PubMed ID: 7602474
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure.
MacPhee IA; Spreafico S; Bewick M; Davis C; Eastwood JB; Johnston A; Lee T; Holt DW
Kidney Int; 2000 Mar; 57(3):1164-8. PubMed ID: 10720968
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.
Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G
Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of morphine in patients following orthotopic liver transplantation.
Shelly MP; Quinn KG; Park GR
Br J Anaesth; 1989 Oct; 63(4):375-9. PubMed ID: 2818915
[TBL] [Abstract][Full Text] [Related]
14. Contribution of morphine and morphine-6-glucuronide to respiratory depression in a child.
Hannam JA; Anderson BJ
Anaesth Intensive Care; 2012 Sep; 40(5):867-70. PubMed ID: 22934872
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of mycophenolate mofetil in renal transplant recipients on peritoneal dialysis.
Morgera S; Neumayer HH; Fritsche L; Kuchinke S; Lampe D; Ahnert V; Bauer S; Mai I; Budde K
Int J Clin Pharmacol Ther; 1998 Mar; 36(3):159-63. PubMed ID: 9562232
[TBL] [Abstract][Full Text] [Related]
16. Rectal administration of nicomorphine in patients improves biological availability of morphine and its glucuronide conjugates.
Koopman-Kimenai PM; Vree TB; Booij LH; Dirksen R
Pharm World Sci; 1994 Dec; 16(6):248-53. PubMed ID: 7889023
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of morphine in patients with renal failure.
Säwe J; Odar-Cederlöf I
Eur J Clin Pharmacol; 1987; 32(4):377-82. PubMed ID: 3609116
[TBL] [Abstract][Full Text] [Related]
18. The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.
Milne RW; Nation RL; Somogyi AA; Bochner F; Griggs WM
Br J Clin Pharmacol; 1992 Jul; 34(1):53-9. PubMed ID: 1633068
[TBL] [Abstract][Full Text] [Related]
19. Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine.
Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
J Pharmacol Exp Ther; 1997 Aug; 282(2):779-86. PubMed ID: 9262341
[TBL] [Abstract][Full Text] [Related]
20. Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure.
Portenoy RK; Foley KM; Stulman J; Khan E; Adelhardt J; Layman M; Cerbone DF; Inturrisi CE
Pain; 1991 Oct; 47(1):13-19. PubMed ID: 1771088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
